These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11056105

  • 21. Nitric oxide donors regulate nitric oxide synthase in bovine pulmonary artery endothelium.
    Chen JX, Berry LC, Tanner M, Chang M, Myers RP, Meyrick B.
    J Cell Physiol; 2001 Jan; 186(1):116-23. PubMed ID: 11147806
    [Abstract] [Full Text] [Related]

  • 22. CVB infection and mechanisms of viral cardiomyopathy.
    Knowlton KU.
    Curr Top Microbiol Immunol; 2008 Jan; 323():315-35. PubMed ID: 18357777
    [Abstract] [Full Text] [Related]

  • 23. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation.
    Park HS, Huh SH, Kim MS, Lee SH, Choi EJ.
    Proc Natl Acad Sci U S A; 2000 Dec 19; 97(26):14382-7. PubMed ID: 11121042
    [Abstract] [Full Text] [Related]

  • 24. NO donors stimulate noradrenaline release from rat hippocampus in a calmodulin-dependent manner in the presence of L-cysteine.
    Satoh S, Kimura T, Toda M, Miyazaki H, Ono S, Narita H, Murayama T, Nomura Y.
    J Cell Physiol; 1996 Oct 19; 169(1):87-96. PubMed ID: 8841425
    [Abstract] [Full Text] [Related]

  • 25. Protease 2A induces stress granule formation during coxsackievirus B3 and enterovirus 71 infections.
    Wu S, Wang Y, Lin L, Si X, Wang T, Zhong X, Tong L, Luan Y, Chen Y, Li X, Zhang F, Zhao W, Zhong Z.
    Virol J; 2014 Nov 20; 11():192. PubMed ID: 25410318
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice.
    Merl S, Michaelis C, Jaschke B, Vorpahl M, Seidl S, Wessely R.
    Circulation; 2005 Apr 05; 111(13):1583-92. PubMed ID: 15795330
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of clotting factor XIII activity by nitric oxide.
    Catani MV, Bernassola F, Rossi A, Melino G.
    Biochem Biophys Res Commun; 1998 Aug 10; 249(1):275-8. PubMed ID: 9705871
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment.
    Barnabei MS, Sjaastad FV, Townsend D, Bedada FB, Metzger JM.
    Sci Transl Med; 2015 Jul 01; 7(294):294ra106. PubMed ID: 26136477
    [Abstract] [Full Text] [Related]

  • 34. Nitric oxide inhibits neonatal hepatocyte oxidative metabolism.
    Romeo C, Eaton S, Spitz L, Pierro A.
    J Pediatr Surg; 2000 Jan 01; 35(1):44-8. PubMed ID: 10646772
    [Abstract] [Full Text] [Related]

  • 35. Comparative effects of several nitric oxide donors on intracellular cyclic GMP levels in bovine chromaffin cells: correlation with nitric oxide production.
    Ferrero R, Rodríguez-Pascual F, Miras-Portugal MT, Torres M.
    Br J Pharmacol; 1999 Jun 01; 127(3):779-87. PubMed ID: 10401570
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Targeting cysteine residues of human immunodeficiency virus type 1 protease by reactive free radical species.
    Basu A, Sehajpal PK, Ogiste JS, Lander HM.
    Antioxid Redox Signal; 1999 Jun 01; 1(1):105-12. PubMed ID: 11225727
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.